Article ID Journal Published Year Pages File Type
8234665 International Journal of Radiation Oncology*Biology*Physics 2009 4 Pages PDF
Abstract
There are varied practice patterns in physicians' choice of the extent of concurrent ADT when used with brachytherapy for men with intermediate- or high-risk prostate cancer. Given a lack of demonstrated superiority from either ADT choice, both appear to be reasonable options.
Keywords
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Preview
Maximum vs. Mono Androgen Blockade and the Risk of Recurrence in Men With Localized Prostate Cancer Undergoing Brachytherapy
Authors
, , , , , , , ,